Sorry, you need to enable JavaScript to visit this website.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Learn More Learn More

Takeover Banner for StyleGuide

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Style Guide: Page Standards

These are examples of various headers available on Pfizer.com.

This is an H1 Header

This is an H2 Header

This is an H3 Header

This is an H4 Header

This is an H5 Header
This is an H6 Header

This is an example of a standard paragraph: Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Breakout Box Example

Use this module when trying to highlight important information within the body of your text.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Sed augue lacus viverra vitae congue eu consequat. Iaculis nunc sed augue lacus viverra. Sed tempus urna et pharetra. Pulvinar elementum integer enim neque volutpat ac tincidunt vitae semper. Pretium vulputate sapien nec sagittis aliquam malesuada. Aliquet eget sit amet tellus. Quis enim lobortis scelerisque fermentum dui faucibus. Euismod in pellentesque massa placerat duis ultricies lacus sed turpis. Pulvinar elementum integer enim neque. Turpis egestas sed tempus urna et pharetra pharetra massa.

Header Title

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Click here to learn more

Sit amet tellus cras adipiscing enim eu turpis egestas. In arcu cursus euismod quis viverra nibh cras pulvinar mattis. Porttitor leo a diam sollicitudin tempor id eu nisl nunc. Sed sed risus pretium quam vulputate dignissim suspendisse in. Blandit turpis cursus in hac habitasse. Massa eget egestas purus viverra accumsan in nisl. Euismod elementum nisi quis eleifend quam adipiscing vitae proin. Ac felis donec et odio pellentesque diam volutpat commodo sed. Eget mi proin sed libero enim sed faucibus turpis. In metus vulputate eu scelerisque felis imperdiet proin. Lectus arcu bibendum at varius vel pharetra vel. Molestie a iaculis at erat pellentesque.Vel eros donec ac odio tempor orci dapibus. Urna et pharetra pharetra massa massa ultricies mi. Nulla facilisi nullam vehicula ipsum a arcu cursus vitae. Varius vel pharetra vel turpis nunc eget lorem dolor. Volutpat lacus laoreet non curabitur gravida arcu ac tortor dignissim. Donec ultrices tincidunt arcu non. Eget magna fermentum iaculis eu non diam phasellus vestibulum lorem. Elementum nisi quis eleifend quam adipiscing. Est ultricies integer quis auctor elit. Sed sed risus pretium quam vulputate dignissim suspendisse. Ridiculus mus mauris vitae ultricies leo integer malesuada nunc vel. Dolor sit amet consectetur adipiscing elit duis tristique sollicitudin nibh. In nisl nisi scelerisque eu ultrices vitae auctor eu augue. Sagittis id consectetur purus ut faucibus pulvinar. Enim sit amet venenatis urna cursus. Rhoncus urna neque viverra justo nec ultrices dui sapien. Pretium aenean pharetra magna ac placerat. Et tortor consequat id porta. Tellus cras adipiscing enim eu turpis egestas pretium aenean pharetra.

 

 

 

 

Image Alignment Examples

When trying to highlight images (left, center, right) within the body of your text.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Nibh nisl condimentum id venenatis. Suscipit adipiscing bibendum est ultricies integer quis auctor. Quam adipiscing vitae proin sagittis nisl rhoncus mattis rhoncus urna. Consectetur adipiscing elit duis tristique sollicitudin nibh sit amet. Cursus turpis massa tincidunt dui ut ornare lectus sit. Arcu cursus euismod quis viverra nibh cras pulvinar. Sed sed risus pretium quam vulputate. Eu lobortis elementum nibh tellus molestie. Pretium vulputate sapien nec sagittis aliquam malesuada bibendum. Dapibus ultrices in iaculis nunc sed augue lacus viverra. Nulla aliquet enim tortor at auctor urna nunc. Malesuada pellentesque elit eget gravida cum sociis natoque penatibus. Nisl purus in mollis nunc. Viverra aliquet eget sit amet.

Dictum sit amet justo donec enim diam vulputate ut. Neque viverra justo nec ultrices dui. Est ante in nibh mauris cursus mattis molestie a iaculis. Ut enim blandit volutpat maecenas volutpat blandit aliquam etiam. Habitant morbi tristique senectus et netus et malesuada fames. Enim lobortis scelerisque fermentum dui faucibus in ornare quam. Aliquam ut porttitor leo a diam. Nisi porta lorem mollis aliquam. Faucibus purus in massa tempor nec feugiat. Odio pellentesque diam volutpat commodo sed egestas. Proin fermentum leo vel orci porta non pulvinar.

Faucibus ornare suspendisse sed nisi lacus. Pretium lectus quam id leo in vitae turpis massa. Mauris a diam maecenas sed. At varius vel pharetra vel turpis nunc eget. In mollis nunc sed id semper. Ac felis donec et odio. Diam in arcu cursus euismod quis viverra nibh. Phasellus vestibulum lorem sed risus ultricies tristique. Vitae aliquet nec ullamcorper sit. Faucibus et molestie ac feugiat sed. Blandit cursus risus at ultrices mi tempus imperdiet. Eu volutpat odio facilisis mauris sit amet massa vitae. Nunc aliquet bibendum enim facilisis gravida. Quam nulla porttitor massa id neque aliquam vestibulum morbi.

Expandable Content

The expandable content section is useful for information in FAQ format or where key topics can be highlighted. You can see specific live examples within our Rare Diseases pages. Standard markup is allowed within this section.

FAQ Test

  • Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

  • Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

  • Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Related Articles

Use the Related Articles section to highlight specific Hot Topic articles that you would want to feature within the body of your page. There is a minimum requirement of 3 Featured Articles in order to use this section.

Person Content

The Person View can be used to highlight biographies of leaders and team members.

The following rules apply:

  • Images must be:
    • High resolution 
    • Uncropped
    • Landscape orientation (portrait orientation requires extensive image manipulation on our end and will affect quality)
  • All images must contain a white background for consistency across the site (example: Link 1).
  • Individuals can only have 1 biography. If an individual is highlighted in more than one area (example: scientist and board member) then please ensure the person's bio reflects this properly.
  • Each person requires: Full name, title, image and biography
ab_headshot_2021_300x170.jpg

Chairman and Chief Executive Officer

Sally-Susman-2022_300x170_2.jpg

Chief Corporate Affairs Officer, Executive Vice President

payal_2021_300x170.jpg

Chief People Experience Officer, Executive Vice President

MikeMcDermott_300x170.jpg

Chief Global Supply Officer, Executive Vice President

Aamir Malik

Chief U.S. Commercial Officer, Executive Vice President

d_lankler_headshot_300x170.jpg

General Counsel, Executive Vice President

Media Name: rady-johnson300x170px.jpg

Chief Compliance, Quality and Risk Officer, Executive Vice President

Alexandre_de_Germay_300X170.jpg

Chief International Commercial Officer, Executive Vice President

Media Name: lidia_fonseca300x170.jpg

Chief Digital and Technology Officer, Executive Vice President

Media Name: mikael_dolsten300x170_2019_v3.jpg

Chief Scientific Officer, President, Pfizer Research & Development

dave_denton_300x170.jpg

Chief Financial Officer and Executive Vice President

chris_boshoff_300x170_v1.jpg

Chief Oncology Officer, Executive Vice President

ab_headshot_2021_300x170.jpg

Chairman and Chief Executive Officer

Sally-Susman-2022_300x170_2.jpg

Chief Corporate Affairs Officer, Executive Vice President

payal_2021_300x170.jpg

Chief People Experience Officer, Executive Vice President

MikeMcDermott_300x170.jpg

Chief Global Supply Officer, Executive Vice President

Aamir Malik

Chief U.S. Commercial Officer, Executive Vice President

d_lankler_headshot_300x170.jpg

General Counsel, Executive Vice President

Media Name: rady-johnson300x170px.jpg

Chief Compliance, Quality and Risk Officer, Executive Vice President

Alexandre_de_Germay_300X170.jpg

Chief International Commercial Officer, Executive Vice President

Media Name: lidia_fonseca300x170.jpg

Chief Digital and Technology Officer, Executive Vice President

Media Name: mikael_dolsten300x170_2019_v3.jpg

Chief Scientific Officer, President, Pfizer Research & Development

dave_denton_300x170.jpg

Chief Financial Officer and Executive Vice President

chris_boshoff_300x170_v1.jpg

Chief Oncology Officer, Executive Vice President

ab_headshot_2021_300x170.jpg

Chairman and Chief Executive Officer

Sally-Susman-2022_300x170_2.jpg

Chief Corporate Affairs Officer, Executive Vice President

payal_2021_300x170.jpg

Chief People Experience Officer, Executive Vice President

MikeMcDermott_300x170.jpg

Chief Global Supply Officer, Executive Vice President

Aamir Malik

Chief U.S. Commercial Officer, Executive Vice President

d_lankler_headshot_300x170.jpg

General Counsel, Executive Vice President

Media Name: rady-johnson300x170px.jpg

Chief Compliance, Quality and Risk Officer, Executive Vice President

Alexandre_de_Germay_300X170.jpg

Chief International Commercial Officer, Executive Vice President

Media Name: lidia_fonseca300x170.jpg

Chief Digital and Technology Officer, Executive Vice President

Media Name: mikael_dolsten300x170_2019_v3.jpg

Chief Scientific Officer, President, Pfizer Research & Development

dave_denton_300x170.jpg

Chief Financial Officer and Executive Vice President

chris_boshoff_300x170_v1.jpg

Chief Oncology Officer, Executive Vice President

ab_headshot_2021_300x170.jpg

Chairman and Chief Executive Officer

Sally-Susman-2022_300x170_2.jpg

Chief Corporate Affairs Officer, Executive Vice President

payal_2021_300x170.jpg

Chief People Experience Officer, Executive Vice President

MikeMcDermott_300x170.jpg

Chief Global Supply Officer, Executive Vice President

Aamir Malik

Chief U.S. Commercial Officer, Executive Vice President

d_lankler_headshot_300x170.jpg

General Counsel, Executive Vice President

Media Name: rady-johnson300x170px.jpg

Chief Compliance, Quality and Risk Officer, Executive Vice President

Alexandre_de_Germay_300X170.jpg

Chief International Commercial Officer, Executive Vice President

Media Name: lidia_fonseca300x170.jpg

Chief Digital and Technology Officer, Executive Vice President

Media Name: mikael_dolsten300x170_2019_v3.jpg

Chief Scientific Officer, President, Pfizer Research & Development

dave_denton_300x170.jpg

Chief Financial Officer and Executive Vice President

chris_boshoff_300x170_v1.jpg

Chief Oncology Officer, Executive Vice President

Brightcove Video Layouts

Our Brightcove capabilities include Gallery Experiences for single and multi-video interfaces. We are also capable of displaying YouTube videos in any gallery as long as they are published within the Pfizer YouTube channel and are not unlisted/private.

Horizontal Playlist Example

 

Live production examples: Link 1

When to use: Multiple videos that are connected by theme or category.

 

Grid Playlist Example

 

Live production examples: Link 1

When to use: Multiple videos that are connected by theme or category and where space utilization on the screen is a concern. Smaller grid footprint allows for several combinations of grids (2 column/3 column layouts) and multiple rows.

 

Single Video Example
 


Live production examples: Link 1

When to use: Single video presentation.

Two-Column Wrapper (Two-Column Links)

Listed below are examples on how our two-column wrapper component/module is used in various ways.

When to use:

  • Highlight an image with quotation or link to a resource.
  • Highlight important text with associated links to pages (internal/external), documents, etc.

"Our postdoctoral fellowship training program focuses on cutting-edge science and technologies that aim to create a knowledge base that will allow us to develop the medicines of the future. Our program provides a unique opportunity for promising scientists to publish breakthrough discoveries that directly impact Pfizer’s next generation therapeutics. Trainees are encouraged to pursue independent research and obtain first-hand knowledge of the drug development process which will help guide their career development in translating basic research into the best medicines imaginable for patients. Importantly, trainees are exposed to all aspects of the pharmaceutical industry and are mentored by scientific leaders in drug discovery, development, and all areas of the business."

 - Seng Cheng, Sr. Vice President & Chief Scientific Officer, Rare Disease Research Unit; Postdoc Program Sponsor

Do you ever have questions on how to safely take your medicines?

Medication errors can happen in clinics and hospitals, pharmacies, and at home. Patients and healthcare providers, however, can work together to help prevent these errors.

Our unique resources allow us to do more for people. Using our global presence and scale, we’re able to make a difference in local communities and the world around us.

  • Our Compliance Program represents a shared undertaking from the highest levels of management to the most junior employees.

    Learn More 

  • We integrate environment, health, and safety (EHS) into how we run our business to ensure that management of risk and regulatory compliance are overseen at the highest levels of the company. With our EHS Policy as the foundation, implementation of Pfizer's EHS Standards and Audit programs establish the performance expectations for colleagues around the world. Each Pfizer colleague plays a crucial role in facilitating a culture of EHS excellence where all improvements, ideas, and opportunities are welcomed. Our governance framework and culture provide the basis for proactive engagement and shared accountability of EHS across our operations.

    Learn More About EHS Governance

  • A network of external suppliers is essential to enable manufacture of medicines and vaccines that deliver breakthroughs that change patients’ lives. Pfizer’s supply chain supports the research, development and manufacturing process by providing flexibility and access to technologies necessary to meet our commitment to patients We are committed to using suppliers that demonstrate strong performance in Environment, Health, and Safety (EHS) management.

    Learn More About EHS Supply Chain 

  • We recognize that environmental issues can result in profound societal and public health impacts.. Our company purpose—Breakthroughs that change patients’ lives—guides our environmental sustainability priorities, with a focus on climate impact mitigation, conservation of resources, and the reduction of waste arising from our operations.

    Learn More About Environmental Sustainability 

  • We continue to invest in the groundbreaking science and technology needed to discover tomorrow’s life-saving treatments for patients who need them the most. Our research, development, and manufacturing facilities across the country are fostering next-generation healthcare innovation while creating 30,000 U.S.-based jobs.

    Learn About Facility Investments

  • All patients should have access to the medicines they need. Through our partnerships with global health institutions and implementation of novel pricing structures–including donations where appropriate–we blend philanthropy and business approaches to increase access to our medicines and vaccines where they’re needed most. 

    Trachoma Initiative

    RxPathways

    Multicultural Health Equity Collective 

    The Gavi Alliance 

    Innovation in Medicine Delivery 

    Disaster and Humanitarian Relief 

    Charitable Contributions 

    Give Forward 

    Global Health Fellows 

    The Pfizer Foundation 

    Ready for Cures

  • We deliver scientific breakthroughs through the relentless collaboration of our talented workforce. Therefore, ensuring the health, safety and well-being of our workforce is critical to delivering our purpose. We continue to advance a comprehensive occupational injury and illness prevention program that enables engagement and productivity.

    Learn More About Health & Safety

  • We’re committed to conducting business in an ethical and responsible manner. This includes respecting internationally recognized human rights throughout our operations.

    Learn More About our Stance on Human Rights

  • The Intellectual Property Principles for Advancing Cures and Therapies (IP PACT) is a groundbreaking, unified declaration of 10 key Intellectual Property (IP) principles. Driven by members of the innovative biopharmaceutical industry, it affirms our strong commitment to innovation and to keeping the needs of patients at the heart of our IP practice

    Learn About IP in Medicines

Chasing a Cure for NASH

You already know that overloading on sweets can lead to diabetes, but it's also driving a silent epidemic: NASH, or non-alcoholic steatohepatitis, which is a severe form of fatty liver disease that's caused by lifestyle factors such as eating too much sugar and not getting enough exercise.

Learn About NASH

Quick Tabs

Listed below are examples of the quick tab component/module.

  • Vertical layout
  • Horizontal layout

When to use: To highlight content/information in a centralized section in tab form to reduce scrolling on the page. Images or infographics can be placed here as well. Two layout options are available.

Gene Therapy

Discovering a breakthrough in the lab is just the beginning. Next comes the challenging work of developing it into a life-transforming treatment for patients.

Learn About Gene Therapy

Acromegaly

Acromegaly is a chronic, rare disease associated with excess growth hormone secretion. It causes overgrowth of body tissues and, if untreated, can lead to secondary problems such as hypertension and heart failure.

Failure to receive adequate medical treatment for this condition can reduce life expectancy by 10 years.

Learn About Acromegaly

 

Duchenne Muscular Dystrophy

Duchenne muscular dystrophy is a rare genetic disease that causes progressive loss of muscle tissue. It affects boys almost exclusively.

Patients typically lose the ability to walk by the time they reach 12 years of age, and often die as a result of respiratory or cardiac failure.

Before treatments were available, children with the disease typically lived into their early teens. But as a result of steroid use and supportive respiratory therapies, many patients now live well into their 20s.

There is still much to be done to allow these patients to live a fuller life.

Learn About Duchenne Muscular Dystrophy

Gaucher Disease

Gaucher (go-SHAY) disease is a rare, inherited condition in which fatty deposits accumulate in critical organs and body systems, causing damage.

The disease is caused by genetic mutations received from both parents.

Learn About Gaucher Disease

Growth Hormone Deficiency

Growth hormone deficiency (also known as dwarfism) is a growth disease associated with inadequate secretion of growth hormone from the pituitary gland, the "master gland" in the brain.

Children with this disease have abnormally short stature with normal body proportions.

Learn About Growth Hormone Deficiency

Hemophilia

Hemophilia is a rare hematological (blood) disease that has been one of our key areas of focus for more than 30 years. Significant progress has been made in the treatment of hemophilia. 

Prior to the 1960s, average life expectancy of a male with severe hemophilia was 12 years of age. 

Today, hemophilia patients who receive treatment can expect to live relatively active and long lives.

However, we believe more can be done to improve treatment for these patients and we are making progress with pioneering approaches to treat the full spectrum of the disease.

Learn About Hemophilia

Sickle Cell Disease

Sickle cell disease is a rare hematological condition that results in misshapen red blood cells, which can block the flow of blood through the body. (Sickle cell anemia is one of the conditions grouped under this disorder.) 

Sickle cell disease can cause intense pain, as well as problems such as stroke, acute chest syndrome, joint damage, kidney issues, and occasionally heart problems.

Learn About Sickle Cell Disease

Transthyretin Amyloidosis

Transthyretin Amyloid Cardiomyopathy (ATTR-CM) is a rare but life-threatening condition that affects the heart and is associated with heart failure.

ATTR-CM is characterized by the build-up of transthyretin amyloid in the heart, which causes the heart muscle to stiffen over time, eventually leading to heart failure.

 

Symptoms of ATTR-CM often mimic those of other more common heart conditions, resulting in the disease being significantly underdiagnosed. Education, awareness, and treatment are critical to improving the diagnosis and care of people affected by ATTR-CM.

Learn About Transthyretin Amyloidosis

Transthyretin Amyloid Polyneuropathy (ATTR-PN) is a rare, progressive, and fatal neurodegenerative disease, which causes an abnormal build-up of amyloid deposits in the peripheral and autonomic nerves, leading to symptoms such as numbness in the feet, dizziness or fainting, abnormal heartbeat, and unintentional weight loss.

ATTR-PN can be difficult to recognize and manage. Misdiagnosis is common and definitive diagnosis can be delayed for years, postponing adequate treatment and genetic counseling, and leading to possible irreversible damage.

Learn About Transthyretin Amyloid Polyneuropathy

Bladder cancer is the 6th most common cancer in the U.S. In 2024, an estimated 80,000 new cases of bladder cancer will be diagnosed in the U.S. Men are four times more likely to be diagnosed with bladder cancer than women. Though the rates of both new bladder cancers and deaths from bladder cancer have been dropping in recent years, many people still face cancer progression and advanced bladder cancer is a common cause of cancer-related death.

Worldwide, breast cancer is the most common invasive cancer, with more than 2.2 million impacted annually. Metastatic breast cancer (mBC), the most advanced stage of breast cancer in which the cancer has spread beyond the breast to other parts of the body (i.e., organs, bones), remains an incurable disease. As a result of earlier screening, increased awareness, and better treatments, breast cancer deaths have continued to decrease in older women. From 2013 to 2018, the death rate went down by 1% per year. 

Cervical cancer begins in the cervix, which is found in the lower part of the uterus that connects to the vagina. In 2024, an estimated over 13,000 new cases of cervical cancer will be diagnosed in the U.S. Despite advances in vaccination and preventative screening practices, approximately 15% of patients present with metastatic disease at diagnosis. Among patients with initial diagnosis of early-stage disease, up to 61% will recur. Recurrent or metastatic cervical cancer is a devastating and mostly incurable disease with an urgent need for more treatment options. Patients who experience disease progression on or after first-line systemic therapy have limited effective therapy choices.

Worldwide, colorectal cancer is the third most common type of cancer in men, and the second most common in women, with approximately 1.8 million new diagnoses in 2018. In the U.S. alone, an estimated 147,950 people will be diagnosed with cancer of the colon or rectum in 2020, and approximately 53,000 are estimated to die of their disease each year. 

Head and neck cancers occur in the larynx, throat, lips, mouth, nose, and salivary glands. About 4% of all cancers in the U.S. are head and neck cancers. These cancers are more than twice as common among men than among women. In 2023, an estimated over 65,000 new cases of head and neck cancer were diagnosed in the U.S. There is a high need for additional effective treatment options for head and neck cancers.

Blood cancers strike ruthlessly at any age. Some come fast and take lives within weeks or months. Others develop in the bones and blood over time, requiring intense and aggressive treatment interventions that are traumatic, emotionally overwhelming, and expensive. More than 1 million people worldwide were diagnosed with a blood cancer in 2020, representing almost 6% of all cancer diagnoses globally. In 2020, more than 700,000 people worldwide died from a form of blood cancer. 

 

Lung cancer remains the leading cause of cancer-related death among men and women globally, and the global five-year survival rate at 17.8 percent is much lower than leading cancers. Lung cancer is notoriously difficult to treat due to the heterogeneous nature of the disease, variability in testing rates and the onset of drug resistance. These challenges necessitate an individualized approach to treatment, ensuring people with lung cancer receive the right drug at the right time.

Though melanoma skin cancer is much less common (1%) than some other types of skin cancers, it causes the vast majority of skin cancer deaths. It is considered more dangerous because it’s much more likely to invade nearby tissue and spread to other parts of the body if not caught and treated early when it is most likely to be cured. 

Prostate cancer is the most common cancer in men in the U.S., aside from non-melanoma skin cancer, and is a leading cause of death from cancer. About 1 in 8 men will be diagnosed with prostate cancer in their lifetimes. Black men are 70% more likely than White men to be diagnosed with prostate cancer. In 2024, an estimated 300,000 new cases of prostate cancer will be diagnosed in the U.S. Though the death rate had been improving, lately this trend has slowed. This change is likely from an increase in later-stage diagnoses that are more difficult to treat.

Featured Slider

Listed below is an example of our featured slider component/module.

When to use: Instead of static tiles on a page which can make it long if there are too many, the slider feature can be used.

Icon Link Tile

Listed below is an example of our icon link tile component/module.

When to use: Instead of images/photos used to navigate to a page or link to a document, icons can be used and made clickable.

Health Literacy Treatment Choices Tips Reporting Counterfeiting Data Sheets

Image Gallery

The Gallery can be used to display images and thumbnails within the body of your page. Allows for scrolling of images/thumbnails. Clicking on the image will open the image in its native resolution.

The following rules apply:

  • Images must be high resolution and quality.
  • Images should be the same size and orientation. The image gallery will work with images of varying sizes but the shift in controls and placement of text will change, reducing overall user experience.
  • There is no upper limit to how many images you can include.
  • Text should be included for each image. This allows for context of what we're looking at and provides some SEO value and page ranking.

Maps Feature

Displayed below is our maps feature component which uses the Google Maps API for styling. The same component can also be used to display as a slider view for each location type that was created.

785X440.jpgNYHQ
This is where the teaser text goes.
785X440.jpgChesterfield, MO
This is where the teaser text goes.
785X440.jpgLake Forest, IL
This is where the teaser text goes.
785X440.jpgSan Diego, CA
This is where the teaser text goes.

Test Area

The Art of Creating New Medicines

Scientists are often lauded for their objectivity, persistence, and analytic thinking. But great scientists have something else in common: they think like artists. And for those who create life-changing medicines, their process is as much an art form as a science.

Go Behind the Science

The Art of Creating New Medicines

Scientists are often lauded for their objectivity, persistence, and analytic thinking. But great scientists have something else in common: they think like artists. And for those who create life-changing medicines, their process is as much an art form as a science.

Go Behind the Science

Pfizer surveyed adults in 10 countries across the Global North and South to better understand the general population's trust in incorporating technology into the management of their healthcare. The results showed that 6 in 10 trust technology in this setting but that means 4 in 10 are at risk of being left behind. Our findings underscored that patients won’t feel the full benefits of that technology if we don’t have trusted people – specifically health care providers – delivering it. We must partner with patients, healthcare providers, policy makers and others in the life sciences and tech industries to build trust in the technologies that are fueling the future of health.

 

Downloadable Infographic